Kestra Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
16,464
-2,130
-11% -$249K 0.04% 135
2026
Q1
$2.24M Sell
18,594
-1,272
-6% -$147K 0.04% 128
2025
Q4
$2.09M Buy
19,866
+377
+2% +$35.4K 0.05% 134
2025
Q3
$1.64M Sell
19,489
-41,301
-68% -$3.4M 0.04% 143
2025
Q2
$5.25M Buy
60,790
+19,683
+48% +$1.56M 0.08% 85
2025
Q1
$3.69M Buy
41,107
+19,752
+92% +$1.84M 0.12% 68
2024
Q4
$2.12M Sell
21,355
-2,063
-9% -$213K 0.08% 79
2024
Q3
$2.66M Buy
+23,418
New +$2.78M 0.11% 68

Other funds holding MRK

Kestra Investment Management's MRK Position: Q2 2026 in Review

Kestra Investment Management reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $249K and leaving 16,464 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #135.

Kestra Investment Management first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.25M in Q2 2025. 2,276 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kestra Investment Management held 16,464 shares of Merck worth $2.12M as of Q2 2026.
  • Kestra Investment Management sold 2,130 Merck shares in Q2 2026, an estimated $249K.
  • Merck made up 0.04% of Kestra Investment Management's portfolio in Q2 2026, its #135 holding.
  • Kestra Investment Management first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • Kestra Investment Management's Merck position peaked at $5.25M in Q2 2025.
  • 2,276 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.